| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.53▲ | 4.55▼ | 4.52▲ | 4.52▲ | 4.24▲ |
| MA10 | 4.54▼ | 4.55▼ | 4.54▼ | 4.47▲ | 4.31▲ |
| MA20 | 4.53▲ | 4.55▼ | 4.51▲ | 4.18▲ | 4.45▲ |
| MA50 | 4.54▼ | 4.49▲ | 4.47▲ | 4.24▲ | 4.26▲ |
| MA100 | 4.49▲ | 4.47▲ | 4.24▲ | 4.46▲ | 4.57▼ |
| MA200 | 4.48▲ | 4.20▲ | 4.16▲ | 4.29▲ | 4.69▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.004▼ | -0.002▼ | 0.060▲ | -0.003▼ |
| RSI | 49.485▼ | 51.076▲ | 53.274▲ | 58.664▲ | 52.801▲ |
| STOCH | 20.741 | 64.012 | 56.481 | 82.134▲ | 39.698 |
| WILL %R | -66.667 | -37.037 | -52.778 | -10.550▲ | -42.308 |
| CCI | -68.852 | -52.209 | -53.333 | 60.073 | 31.389 |
|
Thursday, January 09, 2020 01:00 PM
Shares of ADMA Biologics (NASDAQ:ADMA) were soaring 17.2% higher as of 11:34 a.m. EST on Thursday. The big jump came after the biotech announced its preliminary 2019 Q4 results and provided a ...
|
|
Thursday, January 09, 2020 05:19 AM
ADMA Biologics (NASDAQ:ADMA) is up 10% premarket on announcing preliminary Q4 and FY 2019 revenues, providing updates on the commercial launches of BIVIGAM and ASCENIV, as well as introducing ...
|
|
Thursday, January 09, 2020 04:04 AM
Achieved Fourth Quarter 2019 Preliminary Unaudited Total Revenues of $11.9 Million, a 193% Increase Over Fourth Quarter 2018 Full Year 2019 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/01/20 | 4.465 | 4.585 | 4.45 | 4.535 | 419,520 |
| 22/01/20 | 4.44 | 4.64 | 4.44 | 4.57 | 580,800 |
| 21/01/20 | 4.45 | 4.47 | 4.28 | 4.44 | 730,800 |
| 17/01/20 | 4.61 | 4.65 | 4.39 | 4.46 | 756,700 |
| 16/01/20 | 4.44 | 4.64 | 4.44 | 4.59 | 834,900 |
| 15/01/20 | 4.44 | 4.53 | 4.325 | 4.40 | 514,100 |
| 14/01/20 | 4.32 | 4.50 | 4.24 | 4.44 | 692,600 |
| 13/01/20 | 4.48 | 4.596 | 4.29 | 4.35 | 948,300 |
| 10/01/20 | 4.50 | 4.615 | 4.425 | 4.51 | 1,266,949 |
| 09/01/20 | 4.15 | 4.62 | 4.10 | 4.40 | 3,149,600 |
|
|
||||
|
|
||||
|
|